The Patent Finder

Immunome, Inc.

18 patents currently held · Updated Nov 21, 2026
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 15, 2027
    The maintenance fee for FLUOROALKYL-1,4-Benzodiazepinone Compounds (US 9,133,139) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.
  • 2 fees due May 7 to 17, 2027 · next May 7
  • 1 fee due Jun 5, 2027
    The maintenance fee for Antibody cocktail against SARS-CoV-2 spike protein (US 11,834,493) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
  • 2 fees due Jul 26, 2027
  • 1 fee due Aug 2, 2027
    The maintenance fee for Tricyclic Heterocycle Compounds (US 9,249,157) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
  • 2 fees due Sep 1, 2027

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,629,136BISFLUOROALKYL-1,4-Benzodiazepinone Compounds
In force
 · High confidence
In forceHigh confidence
US 8,822,454BISFLUOROALKYL-1,4-Benzodiazepinone Compounds
In force
 · High confidence
In forceHigh confidence
US 9,427,442Fluoroalkyl and Fluorocycloalkyl 1,4-Benzodiazepinone Compounds
In force
 · High confidence
In forceHigh confidence
US 8,999,918BIS(FLUOROALKYL)-1,4-Benzodiazepinone Compounds and Prodrugs Thereof
In force
 · High confidence
In forceHigh confidence
US 9,133,139FLUOROALKYL-1,4-Benzodiazepinone Compounds
In force
 · High confidence
In forceHigh confidence
US 9,187,434Substituted 1,5-Benzodiazepinones Compounds
In force
 · High confidence
In forceHigh confidence
US 9,242,940N-Substituted BIS(FLUOROALKYL)-1,4-Benzodiazepinone Compounds
In force
 · High confidence
In forceHigh confidence
US 9,242,941Alkyl, FLUOROALKYL-1,4-Benzodiazepinone Compounds
In force
 · High confidence
In forceHigh confidence
US 9,249,157Tricyclic Heterocycle Compounds
In force
 · High confidence
In forceHigh confidence
US 9,273,014BIS(FLUOROALKYL)-1,4-Benzodiazepinone Compounds and Prodrugs Thereof
In force
 · High confidence
In forceHigh confidence
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
Also on record, not counted in the 18: 5 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 abandoned · 7 no status recorded

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/279,615Methods of Preparing Chiral Benzodiazepinone DerivativesJul 24, 2025Pending
18/927,777EPHA2 AntibodiesOct 25, 2024Pending
18/738,096Jun 10, 2024No status recorded
18/493,744Oct 24, 2023No status recorded
18/854,466Apr 5, 2023No status recorded
18/284,527IL-38-Specific AntibodiesMar 28, 2022Abandoned
17/631,102Jul 30, 2020No status recorded
17/283,614Oct 17, 2019No status recorded
17/281,663Oct 2, 2019No status recorded
17/055,646May 17, 2019No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited